This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Otsuka Pharmaceutical. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiaofeng Wang and Aripiprazole Treatment Innovations.
Introduction
Xiaofeng Wang is an inventor associated with Otsuka Pharmaceutical and based in Ellicott City, Maryland. His patent work includes methods for initiating aripiprazole treatment.
Latest Patents
Wang is associated with 2 patents. The supplied patent information describes a method for initiating aripiprazole treatment. On the first day of treatment, a patient receives two separate intramuscular depot injections of aripiprazole, each ranging from 100 to 500 mg, at separate gluteal and/or deltoid injection sites, along with a single oral dose of aripiprazole. The description was provided twice, so it is presented here once.
Career Highlights
Wang’s listed patent activity concerns a dose-initiation approach combining injectable depot and oral aripiprazole on the first day of treatment. The supplied information identifies Otsuka Pharmaceutical as his company.
Collaborations
Matthew Harlin and Yanlin Wang are identified as Wang’s coworkers. The supplied information does not specify their roles in the patent or the described treatment method.
Conclusion
Xiaofeng Wang’s listed patent work focuses on an aripiprazole treatment-initiation method, reflecting his association with pharmaceutical innovation at Otsuka Pharmaceutical.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile